Connect with us

Science & Technology

Is the US government’s Anthropic ban accidentally helping the brand? | Equity Podcast

Just as last week was ending, the US government forced Anthropic to pull its two newest models, Fable 5 and Mythos 5, citing national security concerns after Amazon researchers allegedly found a way to bypass Fable 5’s guardrails. Cybersecurity researchers have since signed an open letter calling the move dangerous, and Anthropic itself noted the…

Published

on

Just as last week was ending, the US government forced Anthropic to pull its two newest models, Fable 5 and Mythos 5, citing national security concerns after Amazon researchers allegedly found a way to bypass Fable 5’s guardrails.

Cybersecurity researchers have since signed an open letter calling the move dangerous, and Anthropic itself noted the same jailbreaks exist in other models. So is this a genuine security concern, or just the latest chapter in a messy relationship between Anthropic and the Trump administration?

On this episode of TechCrunch’s Equity podcast, hosts Anthony Ha, Sean O’Kane, and Rebecca Bellan unpack what the ban means for developers building on Anthropic’s platform and for anyone watching the IPO, why it might accidentally be good for the company, and more of the week’s headlines.

Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod.

Chapters:

00:00 Intro

01:28 The US government pulls Anthropic’s Fable 5 and Mythos 5

03:57 Cybersecurity researchers push back on the ban

06:33 Could the ban actually help Anthropic’s business?

12:26 The UK’s sweeping social media ban for users under 16

21:34 SpaceX acquires Cursor for $60B in stock

28:53 Jeff Bezos’s $12B bet on physical AI with Prometheus

32:04 Outro

Continue Reading
Advertisement
1 Comment

1 Comment

  1. @doubledragon9530

    June 19, 2026 at 7:34 pm

    Opus 4.8 was significantly better than 4.7, I mean qualitatively better. It still got confused on long analyses, however, but Fable, man that thing never let go of its focus, whatever you were exploring, it stayed focused right there with you. I was in the middle of two substantial projects just three days in when they pulled it, and I those two projects are now on hold because, as good as Opus 4.8 is, I’m certain it won’t do as good a job and will require significantly more work from me to bring those to completion. Also, if anything needs to be slowed down, it’s the creation and use of agentic tools because that is where the real security risk is right now, poisoned tools. Check out exploits of Openclaw and vcode to name just two attack surfaces. Adversaries aren’t going after jailbreaking text prompts anymore, they are going after backdooring tools. All of that needs to be locked down, not the models themselves.

Leave a Reply

Your email address will not be published. Required fields are marked *

Science & Technology

Why Raising Your First Round Is Harder Than Ever l Build Mode

Raising your first round has always been hard — but in today’s market, the rules are changing fast. In this episode of Build Mode, our host and Startup Battlefield lead Isabelle Johannesen sits down with Charles Hudson, Founder and Managing Partner of Precursor Ventures, to talk about what early-stage founders need to know before raising…

Published

on

Raising your first round has always been hard — but in today’s market, the rules are changing fast.
In this episode of Build Mode, our host and Startup Battlefield lead Isabelle Johannesen sits down with Charles Hudson, Founder and Managing Partner of Precursor Ventures, to talk about what early-stage founders need to know before raising their first institutional round.
Charles shares a candid look at how the venture landscape has shifted, why AI is changing what investors pay attention to, and how founders can better navigate fundraising when the old playbooks no longer apply.

They get into:
• Why raising pre-seed and seed funding feels harder right now
• How AI is reshaping venture capital
• What founders should know before choosing an investor
• Why the highest valuation is not always the best deal
• How to build momentum during a fundraise
• Why storytelling and a strong blurb matter more than ever
• What happens when a startup raises too much too soon
• Why the biggest risk may not be a down round — but no round at all
• How to think about whether venture capital is actually the right path

Whether you’re preparing to raise, currently fundraising, or just trying to understand how early-stage venture is changing, this conversation is packed with practical, honest advice for founders building in today’s market.

Subscribe to Build Mode on⁠ Apple Podcasts⁠, ⁠Spotify⁠, or⁠ wherever you like to listen⁠. And watch the full videos on⁠ YouTube⁠. New episodes of ⁠Build Mode⁠ drop every Thursday.

Chapters:
00:00 – The New Rules of Startup Fundraising
02:00 – What VCs Look for in First-Time Founders
08:50 – The Biggest Fundraising Mistakes Startup Founders Make
13:20 – Why Startup Valuations Are So Unpredictable in 2026
18:20 – Why Raising Too Much Money Can Hurt Your Startup
25:55 – Should Every Startup Raise Venture Capital?
29:20 – How to Choose the Right VC Investor
33:55 – Why Silicon Valley Still Gives Founders an Advantage
36:40 – How to Build Momentum During a Startup Fundraise

Hosted by Isabelle Johannessen. Produced and edited by Maggie Nye. Audience development led by Morgan Little. Special thanks to the Foundry and Cheddar video teams.

Continue Reading

Science & Technology

You May Care Deeply About Your Startup. The Rest of the World Doesn’t

Nobody has to care: that’s the biggest challenge facing many startups. Not every startup that struggles for funding is a bad business. Sometimes the metrics are strong, growth is real, and the founders have done everything right. The problem? Investors believe the biggest returns are happening somewhere else. In the latest episode of our Build…

Published

on

Nobody has to care: that’s the biggest challenge facing many startups.

Not every startup that struggles for funding is a bad business. Sometimes the metrics are strong, growth is real, and the founders have done everything right.

The problem? Investors believe the biggest returns are happening somewhere else.

In the latest episode of our Build Mode podcast, Charles Hudson of Precursor Ventures explains why great companies can still struggle to raise capital when they’re outside the markets VCs are betting on — and why timing and category matter just as much as execution.

Continue Reading

Science & Technology

Can Ozempic End Addiction? | Dhruv Khullar | TED

What if GLP-1s like Ozempic could do more than just tip the scales? Physician Dhruv Khullar traces the winding path of the “moderation molecule” — from a discovery in Gila monster saliva to a potential diabetes medication and addiction treatment — and how they could quiet the relentless noise of craving. The most surprising effects…

Published

on

What if GLP-1s like Ozempic could do more than just tip the scales? Physician Dhruv Khullar traces the winding path of the “moderation molecule” — from a discovery in Gila monster saliva to a potential diabetes medication and addiction treatment — and how they could quiet the relentless noise of craving. The most surprising effects of GLP-1s may not be in the gut, but in the brain. (Recorded at TED2026 on April 15, 2026)

Join us in person at a TED conference:
Become a TED Member to support our mission:
Subscribe to a TED newsletter:

Follow TED!
Instagram:
LinkedIn:
TikTok:
Facebook:
X:

The TED Talks channel features the best talks and performances from the TED Conference, where the world’s leading thinkers and doers give the talk of their lives in 18 minutes (or less) — plus originals, podcasts and exclusive content. Look for videos on Technology, Entertainment and Design as well as science, business, global issues, the arts and more. Visit for our entire library, transcripts, translations and personalized recommendations.

Watch more:

TED videos may be used for non-commercial purposes under a Creative Commons License, Attribution–Non Commercial–No Derivatives (or the CC BY – NC – ND 4.0 International) and in accordance with the TED Talks Usage Policy: . For more information on using TED for commercial purposes (e.g. employee learning, in a film or online course), submit a request at

#TED #TEDTalks #Science #Health

Continue Reading

Trending